M&A Deal Summary

Integra LifeSciences Holdings Acquires Derma Sciences

On January 10, 2017, Integra LifeSciences Holdings acquired medical products company Derma Sciences

Acquisition Highlights
  • This is Integra LifeSciences Holdings’ 34th transaction in the Medical Products sector.
  • This is Integra LifeSciences Holdings’ 34th transaction in the United States.
  • This is Integra LifeSciences Holdings’ 2nd transaction in New Jersey.

M&A Deal Summary
Date 2017-01-10
Target Derma Sciences
Sector Medical Products
Buyer(s) Integra LifeSciences Holdings
Deal Type Add-on Acquisition

Target

Derma Sciences

Princeton, New Jersey, United States
Derma Sciences, Inc. is an integrated manufacturer, marketer and supplier of dermatological related product lines, including: wound care, wound closure and specialty securement devices, and skin care.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Integra LifeSciences Holdings

Princeton, New Jersey, United States
Category Company
Founded 1989
Sector Medical Products
Employees3,946
Revenue 1.5B USD (2023)
DESCRIPTION

Integra LifeSciences Holdings is a major medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra LifeSciences Holdings was founded in 1989 and is based in Princeton, New Jersey.

DEAL STATS #
Overall 41 of 45
Sector (Medical Products) 34 of 38
Type (Add-on Acquisition) 31 of 33
State (New Jersey) 2 of 2
Country (United States) 34 of 38
Year (2017) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-20 TEI Biosciences

Waltham, Massachusetts, United States

TEI Biosciences, Inc. is a biomedical company that applies its expertise in regenerative medicine to develop and commercialize novel biologic devices, including SurgiMend®, for a broad spectrum of soft tissue repair and regeneration applications – from dura and hernia repair to plastic and reconstructive surgery.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-15 Johnson & Johnson - Codman Neurosurgery Business

Raynham, Massachusetts, United States

Johnson & Johnson - Codman Neurosurgery Business is a global neurosurgery and neurovascular company that offers a broad portfolio of devices for hydrocephalus management, neuro intensive care and cranial surgery, as well as aneurysm coils, vascular reconstruction devices and other technologies used in the endovascular treatment of cerebral aneurysms and stroke.

Buy $1.0B
Mergr

Product

Company

Legal